Flywheel, the leading data management platform for medical research and collaboration, announced it has secured $15 million in Series B funding.

The funding round is being co-led by Beringea and 8VC. Other investors include Novartis dRx Capital, Hewlett Packard Enterprise (HPE), Great North Labs, iSelect and Argonautic Ventures, which has deep knowledge and experience in the life sciences market.

Flywheel is a leading research data platform that provides the tools needed for data import, automated curation, image processing, machine learning workflows, and secure collaboration. By leveraging cloud scalability and automating research workflows, Flywheel helps organizations scale research data and analysis, improve scientific collaboration and accelerate discoveries. Flywheel offers a comprehensive solution for life sciences, pharmaceutical, biotech, academic, and clinical research. Flywheel is headquartered in Minneapolis and has offices in the Bay Area, Washington DC, and Budapest.